Xolair 150 MG/1.2 ML powder VLS
Ended Awarded
- Contract number
- SPE2DB25FN3GK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,203
Award facts
- Contract value 100% obligated
- $7,203.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $7,203.40 to AmerisourceBergen Drug Corp for XOLAIR 150 MG/1.2 ML Powder vials under a firm fixed-price contract. The award was made on July 21, 2025, with an ultimate completion date of August 11, 2025. This is a non-set-aside, competitively awarded delivery order that will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. XOLAIR (omalizumab) is a monoclonal antibody therapy commonly used for treating moderate-to-severe allergic asthma and chronic idiopathic urticaria, making this a specialized pharmaceutical product within the company's broader medical supply portfolio.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications, vaccines, and medical supplies to military healthcare systems worldwide. AmerisourceBergen's position as a major pharmaceutical distributor and critical federal vendor is reflected in its consistent receipt of competitively awarded contracts across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FN3GK?
SPE2DB25FN3GK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FN3GK worth?
The government has obligated $7,203 on SPE2DB25FN3GK.
Is contract SPE2DB25FN3GK an order under another contract?
Yes. SPE2DB25FN3GK is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN3GK competed?
The extent of competition for SPE2DB25FN3GK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award